Success Story: 13-Month NIW Victory Without RFE for Microbiology Scientist from Jamaica

 

Client’s Testimonial:

“Thank you, and it was a pleasure working with the team! :) Super exciting.”


On January 29th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Microbiology (Approval Notice).


General Field: Microbiology

Position at the Time of Case Filing: Scientist

Country of Origin: Jamaica

State of Residence at the Time of Filing: Nevada

Approval Notice Date: January 29th, 2026

Processing Time: 13 months


Case Summary:  

"Through her discoveries in immune mechanisms and contact lens-related corneal health, [Client] has cemented her status as a leading authority in ocular immunology and medical device innovation."

The statement above is taken from one of the two recommendation letters submitted as part of the EB-2 NIW (National Interest Waiver) petition for a scientist holding a Ph.D. in Vision Science from Jamaica with advanced expertise in microbiology.

Client Background and Proposed Endeavor

As an expert in the field of microbiology, the proposed endeavor is to continue mechanistic research on how sensory nerve function and corneal immune responses regulate bacterial adhesion, colonization, and immune tolerance at mucosal surfaces, including the cornea. With extensive training in advanced immunological techniques and innovative analytical methods, this scientist is actively advancing research in ocular immunology and microbiology with direct applications to contact lens safety and eye care innovation. While the eye is used as an important model system, the research addresses broader infection-related questions with relevance to multiple parts of the body.

National Significance of the Research

We emphasized that this research is of significant importance and has far-reaching implications for the United States. The work directly addresses the high risk of infections and immune complications associated with contact lens wear, strengthening public health initiatives nationwide.

This research reveals critical mechanisms that protect the cornea from sight-threatening infections, advancing the development of safer contact lenses and innovative eye treatments. These contributions are critical to reducing healthcare costs related to eye infections and chronic eye conditions, thereby lessening the burden on the national healthcare system. Additionally, the findings drive growth in the national medical device industry by fostering advancements in contact lens technology and eye care products, supporting both economic growth and workforce productivity.

Impressive Credentials and Achievements

To further strengthen the case, we highlighted exceptional credentials:

  • Publications: An impressive portfolio of 5 peer-reviewed journal articles and 4 conference abstracts (1 of them first-authored). The research has been published in esteemed journals
  • Citations: The work has been cited 30 times, demonstrating influence within the scientific community and the practical application of the findings by other researchers advancing the field of ocular immunology.
  • Competitive Funding: The research has been supported by major funding sources, including the National Eye Institute (NEI) and the National Institutes of Health (NIH), affirming the significance and national importance of the work.
Case Outcome

Considering the exceptional strength of the accomplishments and the national importance of the proposed endeavor, we are delighted to share that this NIW petition was approved in 13 months without RFE. The innovative work in corneal immunology and contact lens safety, combined with demonstrated expertise in immune defense mechanisms and medical device innovation, positions this researcher to make transformative contributions to U.S. public health and eye care advancement for years to come.